Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
10,4 USD | +0,97% | -5,20% | -18,43% |
25/03 | Treace Medical Concepts tratta 100.000 pazienti con la Lapiplastica per la correzione del bunione | MT |
27/02 | Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Attività
Numero di dipendenti: 516
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Medical Devices
100,0
%
| 142 | 100,0 % | 187 | 100,0 % | +31,92% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 142 | 100,0 % | 187 | 100,0 % | +31,92% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Treace
FOU | Founder | 52 | 01/01/14 |
Mark Hair
DFI | Director of Finance/CFO | 54 | 01/09/20 |
Scot Elder
CMP | Compliance Officer | 49 | 01/10/22 |
Sean Scanlan
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/01/18 |
Terry Lubben
COO | Chief Operating Officer | - | - |
Shana R. Zink
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julie Dewey
IRC | Investor Relations Contact | - | 17/07/23 |
Nathan Minnich
SAM | Sales & Marketing | - | 21/08/23 |
Rachel Osbeck
LAW | General Counsel | - | 01/01/15 |
Aaron Berutti
SAM | Sales & Marketing | 45 | 01/08/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 66 | 20/11/20 | |
Richard Mott
BRD | Director/Board Member | 65 | 01/03/15 |
James Treace
CHM | Chairman | 77 | 01/07/14 |
John Bakewell
BRD | Director/Board Member | 62 | 20/11/20 |
Lance Berry
BRD | Director/Board Member | 51 | 01/10/22 |
Jane Kiernan
BRD | Director/Board Member | 63 | 01/09/22 |
John Treace
FOU | Founder | 52 | 01/01/14 |
Elizabeth Hanna
BRD | Director/Board Member | 59 | 01/10/21 |
Deepti Jain
BRD | Director/Board Member | 56 | 01/10/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 61 937 218 | 44 640 038 ( 72,07 %) | 1 218 ( 0,001967 %) | 72,07 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-18,43% | 644 Mln | |
+73,17% | 12,38 Mrd | |
-18,74% | 7,92 Mrd | |
+16,15% | 7,2 Mrd | |
+4,81% | 5,84 Mrd | |
+5,99% | 5,07 Mrd | |
+27,07% | 4,53 Mrd | |
-21,67% | 3,88 Mrd | |
-40,82% | 2,23 Mrd | |
+1,49% | 2,02 Mrd |
- Borsa valori
- Azioni
- Azione TMCI
- Società Treace Medical Concepts, Inc.